AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
about
Interactomic and pharmacological insights on human sirt-1Bioinformatics in crosslinking chemistry of collagen with selective cross linkers3D models of MBP, a biologically active metabolite of bisphenol A, in human estrogen receptor α and estrogen receptor βGenome of the human hookworm Necator americanusA quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasisBiP-mediated closing of the Sec61 channel limits Ca2+ leakage from the ERStructural and functional characterization of human peripheral nervous system myelin protein P2Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancerCooccupancy of the outer vestibule of voltage-gated sodium channels by micro-conotoxin KIIIA and saxitoxin or tetrodotoxinA flavin-dependent monooxygenase from Mycobacterium tuberculosis involved in cholesterol catabolismGenome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasitesPharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosisα-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studiesComputational Approaches to Toll-Like Receptor 4 ModulationMolecular docking as a popular tool in drug design, an in silico travelDrug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening MethodologiesComputational approaches in target identification and drug discoveryAnti-malarial Drug Design by Targeting Apicoplasts: New PerspectivesPrinciples and Overview of Sampling Methods for Modeling Macromolecular Structure and DynamicsMachine-learning scoring functions to improve structure-based binding affinity prediction and virtual screeningInsights into Protein-Ligand Interactions: Mechanisms, Models, and MethodsCystoisospora suis - A Model of Mammalian CystoisosporosisSurfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI InhibitorsA review of metabolic and enzymatic engineering strategies for designing and optimizing performance of microbial cell factoriesProtein flexibility in docking and surface mappingMultiple Drug Transport Pathways through Human P-Glycoprotein.Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational ApproachMolecular dynamic simulations reveal the structural determinants of Fatty Acid binding to oxy-myoglobinDiscovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasisCardiac contractility structure-activity relationship and ligand-receptor interactions; the discovery of unique and novel molecular switches in myosuppressin signalingStructure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studiesEffects of Small Molecule Calcium-Activated Chloride Channel Inhibitors on Structure and Function of Accessory Cholera Enterotoxin (Ace) of Vibrio choleraeMechanism of p27 Unfolding for CDK2 Reactivation.Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 PathwaysInteractions of L-3,5,3'-Triiodothyronine [corrected], Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding ModesThe evolutionary portrait of metazoan NAD salvageBinding interaction of a gamma-aminobutyric acid derivative with serum albumin: an insight by fluorescence and molecular modeling analysisRational design of small molecule inhibitors targeting the Ras GEF, SOS1.Physicochemical characterization of a thermostable alcohol dehydrogenase from Pyrobaculum aerophilumIdentification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein
P2860
Q21129288-9FD0A85C-F9DD-4264-99D2-04D2639E0A4CQ21199597-586FB56A-A783-4429-98E7-E285F3D10CAEQ21560757-EE0272C3-C3E5-464D-ACD4-21260F02BF4EQ22122067-AAB30559-C33E-496D-955B-10864990ACC2Q23005474-928453CA-63E4-49E8-9EBF-BCBB13260764Q24293288-3517C35C-9425-47E2-9BEE-06C7A0BA94E0Q24307936-718E7817-D456-4479-AB3B-F64BAC65D1CAQ24336620-95F3F46C-0208-436D-950D-4395376F6B46Q24609009-FC766575-41D2-48F4-9160-A258C31BAA71Q24609899-5A6707AD-2A1D-4AF7-BB36-ECC77831F0DDQ24625172-641644E0-B20E-45BD-BB56-29BB4547A95CQ24629969-A53E14EF-2381-4F19-BD57-EA1408801BD5Q24632720-716BD34C-8373-4483-A4A7-AAB91C7EA9A4Q26740008-D4E2F9FE-C441-4884-BA66-E04CB41067E7Q26743663-D45757B8-2A23-4EF7-AD1C-F879B8DD70F8Q26745421-734DE23B-B46B-4179-84C6-543B09F8F3E2Q26746941-2A022E6A-C223-411A-A01B-27C685DE89DDQ26747361-4453593F-0500-4481-90F4-EC26F4F8C60CQ26749162-C8AC28FB-05EA-4DE4-A5D2-85BE642BAA3BQ26750642-45718452-A212-4E7A-9B02-320591845796Q26773062-97300405-82FA-4541-99CE-5D1778B50247Q26776047-38ACABA9-9973-487A-AE48-64D7EE868B82Q26823990-CC60AC85-49B4-42C2-A54E-CB2330E9FD41Q26828848-9D0FF3D0-62FC-4456-A44D-5D807800C4F9Q26864013-A42CA037-4FAA-4D08-B3C4-3E73BE81E26BQ27301793-DDC22E92-E979-4FDA-8A7B-3BDA0E1FE42CQ27303614-A4015BA1-25C1-4058-89B8-720460CA94D1Q27305203-C60889FB-E9F9-4FE8-9850-A4A4F0A67B26Q27309876-64BF59CD-81B8-47EF-98C1-76A76CE9A3EEQ27311427-FDB383AE-B882-4427-A81F-7BCD64DE48F0Q27311652-7ABB8E4C-DDBF-4FEC-B47F-BE4F642956E6Q27312038-B4728F54-BF89-41CD-B90F-73FCB831119BQ27313253-E5EF6407-C2C9-4B64-8F69-63B2364C1A9BQ27315022-0FAD7541-F192-4D41-A1F5-A57FBA28DA13Q27316335-21B0CC8A-BF29-4109-A815-42BDE3BE97C5Q27318392-897730D5-E1A7-4C07-A13C-CEBA9C8BC022Q27318662-9DB5BF8B-FA7F-4E51-9A48-B27B7BAF04BCQ27318713-1016D076-10A7-4B61-8D85-4861E5210BEBQ27320034-B97C0667-4208-4671-9DDE-2B8F43C62C73Q27333881-344F5992-1E95-4958-88D6-E7B1AB34AB4D
P2860
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
@ast
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
@en
type
label
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
@ast
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
@en
prefLabel
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
@ast
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
@en
P2093
P2860
P3181
P356
P1476
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
@en
P2093
Arthur J Olson
David S Goodsell
Michel F Sanner
Richard K Belew
William Lindstrom
P2860
P304
P3181
P356
10.1002/JCC.21256
P407
P577
2009-12-01T00:00:00Z